Alessandro Riva

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Travis Thompson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alessandro Riva:

Company Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. Director Ordinary Shares 56,940 $13,944,606 $244.90 21 May 2025 Direct
BICYCLE THERAPEUTICS PLC Director Ordinary Shares 19,880 $187,500 $15.00 02 Jan 2026 Direct
Century Therapeutics, Inc. Director Stock Option (right to buy) 44,000 12 Jun 2025 Direct
BeiGene, Ltd. Director Share Option (Right to Buy) 22,750 21 May 2025 Direct
BICYCLE THERAPEUTICS PLC Director Stock Option (right to buy) 14,761 02 Jan 2026 Direct

Insider Reports Filed by Alessandro Riva

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCYC BICYCLE THERAPEUTICS PLC 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 20:00
IPSC Century Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 18:25
ONC BeiGene, Ltd. 21 May 2025 2 $0 4 Director 22 May 2025, 19:44
BCYC BICYCLE THERAPEUTICS PLC 25 Mar 2025 2 $0 4 Director 27 Mar 2025, 17:17
BCYC BICYCLE THERAPEUTICS PLC 25 Mar 2025 0 $0 3 Director 27 Mar 2025, 17:16
IPSC Century Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:50
ONC BeiGene, Ltd. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 16:57
IPSC Century Therapeutics, Inc. 27 Jun 2023 1 $0 4 Director 29 Jun 2023, 16:22
ONC BeiGene, Ltd. 15 Jun 2023 2 $0 4 Director 20 Jun 2023, 19:01
ONC BeiGene, Ltd. 22 Jun 2022 2 $0 4 Director 24 Jun 2022, 17:38
IPSC Century Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:23
ONC BeiGene, Ltd. 28 Feb 2022 1 $0 4 Director 02 Mar 2022, 16:10
ONC BeiGene, Ltd. 01 Feb 2022 0 $0 3 Director 07 Feb 2022, 17:03
IPSC Century Therapeutics, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 16:31
IPSC Century Therapeutics, Inc. 17 Jun 2021 0 $0 3 Director 17 Jun 2021, 17:02